ArticleNeurology(R) neuroimmunology & neuroinflammation2023

Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis.

Samantha Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.